Maternal chronic infection as a risk factor in preterm low birth weight infants: the link with periodontal infection

Andrés R Sánchez1, Leo I Kupp, Phillip J Sheridan

  • 1Division of Periodontics, Department of Dental Specialties, Mayo Clinic W4A, 200 First Street SW, Rochester, MN 55905, USA. dr_a_sanchez@hotmail.com

Insights

Periodontal disease may increase the risk of preterm low birthweight (PLBW) infants. Further research is needed to confirm fetal exposure to periodontal pathogens and effective treatments for reducing PLBW risk.

Area of Science:

  • Periodontology
  • Obstetrics
  • Public Health

Background:

  • Periodontal disease is increasingly recognized as a potential risk factor for adverse pregnancy outcomes.
  • Preterm low birthweight (PLBW) infants represent a significant public health concern.
  • Chronic infections, including periodontal infections, are being investigated for their role in pregnancy complications.

Purpose of the Study:

  • To review the scientific evidence linking periodontal infections with adverse pregnancy outcomes, specifically preterm low birthweight (PLBW).
  • To summarize epidemiological studies on the relationship between PLBW and infection.
  • To identify areas for future research regarding periodontal disease and PLBW.

Main Methods:

  • Literature review of scientific evidence and epidemiological studies.
  • Focus on the definition, incidence, and risk factors of PLBW.
  • Analysis of the link between chronic infections and PLBW, with a specific emphasis on periodontal infections.

Main Results:

  • Limited available data support the hypothesis that periodontal disease is a risk factor for PLBW infants.
  • Current evidence suggests a potential association between periodontal infections and adverse pregnancy outcomes.

Conclusions:

  • Periodontal disease may contribute to the risk of preterm low birthweight infants.
  • Further research is required to confirm fetal exposure to periodontal pathogens, understand placental transfer mechanisms, and evaluate periodontal treatment efficacy in reducing PLBW risk.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...